Clinical Trials Browser

UNKNOWN × Squamous Cell Carcinoma of Head and Neck × camrelizumab × Clear all

NCT04861467 2021-04-27

Camrelizumab as a Maintenance Therapy After Chemoradiation in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma

Phase 2 Unknown

Squamous Cell Carcinoma of Head and Neck